Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: a French nationwide study from the Epithor cohort database-Reference-Cited by-同舟云学术

Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: a French nationwide study from the Epithor cohort database

Published:2023-03 Issue: Volume:26 Page:100566
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Alifano Marco^ORCID,Daffré Elisa,Brouchet Laurent,Falcoz Pierre Emmanuel^ORCID,Le Pimpec Barthes Françoise,Pages Pierre Benoit,Thomas Pascal Alexandre,Dahan Marcel,Porcher Raphael

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference61 articles.

1. Current surgical indications for non-small-cell lung cancer;Deboever;Cancers (Basel),2022

2. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Postmus;Ann Oncol,2017

3. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Detterbeck;Chest,2013

4. The reality of lung cancer paradox: the impact of body mass index on long-term survival of resected lung cancer. A French nationwide analysis from the Epithor database;Alifano;Cancers,2021

5. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study;Lu;Lancet Digit Health,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study;Respiratory Medicine and Research;2024-11

2. Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox;Thorax;2024-02-15

3. Étude rétrospective monocentrique exploratoire de l’impact de la préexistence d’une pneumopathie interstitielle sur les résultats de la chirurgie pour cancer du poumon (CP-PID);Revue des Maladies Respiratoires Actualités;2024-01

4. In Patients With Early Stage NSCLC Without Driver Mutation After Surgical Resection and Chemotherapy: Adjuvant Atezolizumab Should Only Be Given for Patients With Programmed Death-Ligand 1 Greater Than or Equal to 50%;Journal of Thoracic Oncology;2023-03